Drug Profile
FE 999011
Alternative Names: FE-999011Latest Information Update: 21 Nov 2006
Price :
$50
*
At a glance
- Originator Ferring Pharmaceuticals
- Class Antihyperglycaemics; Pyrrolidines; Small molecules
- Mechanism of Action Dipeptidyl peptidase 4 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Type 2 diabetes mellitus
Most Recent Events
- 28 May 2002 Preclinical trials in Type-2 diabetes mellitus in Switzerland (unspecified route)